Status:
ACTIVE_NOT_RECRUITING
Multidisciplinary Support To Access Living Donor Kidney Transplant-Pilot
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
University Hospital Foundation
Conditions:
Living Donor Kidney Transplantation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
For patients with kidney failure the two treatment options are kidney transplantation or dialysis. Transplantation offers longer survival, better quality of life and provides cost savings for the heal...
Detailed Description
Living donor kidney transplantation is the optimal treatment for end-stage kidney disease patients, dramatically improving survival and quality of life, providing significant cost saving compared with...
Eligibility Criteria
Inclusion
- English speaking
- No obvious contraindication to kidney transplantation
- Completed 'introduction to kidney transplant' module
Exclusion
- Potential Living Kidney Donor identified
- Previously received organ transplant
- Candidate for multi-organ transplant
- Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) Score \> 20
- Rapid Estimate of Adult Literacy in Medicine (REALM-66) score \< 19 (illiterate in English)
Key Trial Info
Start Date :
May 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2026
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04666545
Start Date
May 12 2021
End Date
September 1 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital
Edmonton, Alberta, Canada